Hatch-Waxman Provision Splits High Court In Generics Row
By Jacqueline Bell ( December 5, 2011, 7:50 PM EST) -- The justices of the U.S. Supreme Court appeared to be divided Monday on the proper interpretation of a Hatch-Waxman Act provision in Caraco Pharmaceutical Laboratories Inc.'s ongoing fight to introduce a rival generic version of a Novo Nordisk A/S diabetes drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.